15 Huang-Lian-Jie-Du-Tang (HLJDT), comprising Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex 16 and Gardeniae Fructus, is one of the commonly used Chinese medicine formulas for clearing heat and 17 detoxifying. Quality control of the herbal complex like Chinese medicine formulas still remains a challenge. 18 The successful approval of botanical drug Veregen by FDA indicated the importance of quantitative analysis in 19 quality control of herbal medicines. In this study, an effective quantitative method based on conventional 20 HPLC-DAD was developed for simultaneous determination of fourteen major ingredients (seven alkaloids, 21 four flavonoids, three terpenes) in HLJDT. The established method was well validated in terms of linearity, 22 sensitivity, precision, accuracy and stability and then successfully applied to quality evaluation of commercial 23 HLJDT samples. The developed method can quantitatively determine up to 70% of the chemicals of 24 commercial HLJDT sample and effectively revealed the significant variation in the quality of the commercial 25 HLJDT samples collected from different locations. 26 27
Introduction

30
Huang-Lian-Jie-Du-Tang (HLJDT), one of often used Chinese medicinal prescriptions, which is composed 31 of four commonly used medicinal herbs, namely Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex 32 and Gardeniae Fructus in 3:2:2:3 proportions, is historically employed for clearing heat and detoxifying [1] .
33
Current studies manifested that alkaloids (mostly isoquinoline alkaloids) from Coptidis Rhizoma and 34 Phellodendri Cortex, flavonoids from Scutellariae Radix and terpenes (largely iridoid glycosides) from 35 Gardeniae Fructus are the major active components in HLJDT and therefore are normally regarded as markers 36 for quality control of HLJDT [2] [3] [4] [5] [6] [7] .
37
In view of the popular use of HLJDT in Asia countries and the lack of agreed quality standard for the 38 commercial HLJDT, quality control is crucial for ensuring its safety and efficacy. Additionally, because of the 39 complicated chemical properties of HLJDT, if possible, the method for quality evaluation of HLJDT should be 3 furthest comprehensive to take account of all kinds of active components. In recent years, seldom analytical 41 methods have been proposed and developed for quality evaluation of HLJDT. Even in these reported methods, 42 only eight or less compounds were used as chemical markers for quality evaluation of HLJDT [8] [9] [10] . These 43 methods are far powerful and reasonable since there are still many undetermined peaks (compounds) in the 44 chromatograms given in these studies. Furthermore, these methods were only applied to self-made but not any 45 commercial samples.
46
As known, it is very difficult for botanical drugs to get approved by FDA (Food and Drug Administration, 47 USA) due to their obscure and complicated chemical components. FDA asserted that comprehensive quality 48 control methods must be issued if the active ingredients of botanical drugs are not definitely confirmed [11] .
49
Up to now, only two botanical drugs derived from herbal extracts with complex chemical profiles, namely 50 Fulyzaq and Veregen, were approved by FDA in 2013 and 2006 respectively, in which up to 90% components 51 were controllable [11, 12] . On the other hands, however, the quality control of herbal medicines are 52 commonly based on several chemical components, which only account for about 10% (even lower) total herbal 53 materials [13, 14] . It is obviously unreasonable and could not far meet the requirements of FDA. Thus, 54 developing more powerful quantitative methods is urgent for quality evaluation of herbal medicines, especially 55 traditional herbal formulas.
56
Hereby, a comprehensive analytical approach using multiple wavelengths HPLC-DAD on simultaneously 57 determination of fourteen components, including seven isoquinoline alkaloids (berberine, palmatine, 58 jatrorrhizine, coptisine, phellodendrine, epiberberine and magnoflorine), four flavonoids (baicalin, wogonin, 59 baicalein and wogonoside) and three terpenes (two iridoid glycosides: geniposide and genipin-1-β-D-60 gentiobioside; one diterpene: crocin I) was established and validated, and then successfully applied to quality 61 evaluation of commercial HLJDT samples. The commercial HLJDT samples (HLJDT-01 to HLJDT-09) were purchased from different pharmacy shops 66 in Zhejiang, Sichuan, and Taiwan provinces, China and sample HLJDT-10 was purchased from Tokyo, Japan 67 (Table 1) . The voucher specimens were deposited at School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
by Millipore Milli Q-Plus system (Millipore, Bedford, MA, USA).
72
The reference compounds ( Fig. 1) , berberine, palmatine, jatrorrhizine, coptisine, epiberberine, magnoflorine, 73 geniposide, baicalin, baicalein, wogonoside, wogonin and crocin I were purchased from Shanghai Yuanye Bio-74 Technology Co., Ltd. (Shanghai, China), and the other two reference compounds, phellodendrine and genipin-75 1-β-D-gentiobioside were bought from Shanghai Shifong Bio-Technology Co., Ltd. (Shanghai, China). All of 76 them were confirmed by their MS spectra before use. 77
Sample preparation
78
The sample powder was homogeneously pulverized (60-80 mesh), accurately weighed (approximately 79 0.0200 g) and then ultrasonic extracted with 10 mL 70% methanol for 30 min. After the powder was well 80 dissolved by mechanically vibration (no any obvious megascopic particles could be found in the solution), the 81 solution were filtered through a 0.22 µm nylon-membrane filter (Millipore, Barcelone) prior to injection into 82 the HPLC system. The method for quantitative analysis was validated in terms of linearity, sensitivity, precision, accuracy and 95 stability. 70% methanol stock solutions of fourteen reference compounds were diluted to appropriate 96 concentrations for the construction of calibration curves. At least eight concentrations of the solution were 97 analyzed in duplicate, and then the calibration curves were constructed by plotting the peak areas versus the 98 concentration of each analyte. The stock solutions were diluted to a series of appropriate concentrations with 99 70% methanol, and an aliquot of the diluted solutions were injected into HPLC for analysis. The limits of 100 detection (LODs) and limits of quantification (LOQs) under the present chromatographic conditions were 101 determined at a signal-to-noise ratio (S/N) of about 3 and 10, respectively. Intra-and inter-day variations were 102 chosen to determine the precision of the developed assay. For intra-day variability test, the sample HLJDT-10 103 was extracted and analyzed for six replicates within one day, while for inter-day variability test, the same 104 sample was examined in duplicates for consecutive three days. Variations were expressed by the RSDs of the 105 data. The spiked recovery test was used to evaluate the accuracy of the method. The recovery was performed 106 by adding a known amount of individual standards into a certain amount (0.0100 g) of sample HLJDT-10. In sample preparation procedure, multifarious solvents, such as different concentrations (10%, 30% 50%, 115 70% and 90%) of ethanol and methanol, were tested and 70% methanol solution was selected because of its 116 excellent dissolving capacity for HLJDT sample. For HPLC analysis, two mobile phase systems, including 117 acetonitrile-water and methanol-water, in various proportions were compared and different mobile phase 118 additive, such as phosphate buffer, formic acid and acetic acid were also investigated, and finally, 0.1% formic 119 acid aqueous solution and methanol containing 0.1% formic acid were used as mobile phases which could 120 provide satisfactory separation and peak shapes of all fourteen investigated compounds. In addition, determine 121 6 wavelengths for these different kinds of analytes were also optimized for improving sensitivity. Finally, in 122 consideration of corresponding maximum ultraviolet absorptions of the analytes, three ultraviolet wavelengths, 123 254 nm, 275 nm and 440 nm, were respectively chosen for detection. 124
Method validation 125
The linearity, regression and linear ranges of fourteen analytes were summarized in Table 2 . The data 126 indicated good relationship between concentrations and peak areas of the analytes within the test ranges 127 (R 2 ≥0.9990). The LOQs and LODs of all analytes were less than 1.06 and 0.41 µg/mL on column, respectively.
128
It is worth mentioning that the LOD and LOD values in this study were much lower than those in previous 129 publications [8] [9] [10] , which demonstrated that the newly developed method is more sensitive. The overall RSDs 130 of intra-and inter-day variations for fourteen analytes were not more than 4.49 % and 6.54 %, respectively.
131
The established method also had acceptable accuracy with spike recovery of 95.50-104.92 % for all analytes.
132
As to stability test, the RSDs of the peak areas for fourteen analytes detected within 24 h were lower than 133 4.25 %. All these results demonstrated that the developed HPLC method was sufficiently reliable and accurate 134 for simultaneous quantification of the fourteen investigated compounds in HLJDT. investigated compounds in ten commercial HLJDT samples were summarized in Table 1 .
143
As shown in Table 1 , the contents of fourteen analytes varied greatly in different HLJDT samples. In the 144 sample HLJDT-10, all investigated compounds could be detected and baicalin was the most abundant. More 145 impressively, the total contents of fourteen analytes in this sample reached to 70.83% (of the sample material 146 weight), which inspired that the developed method might be quite suitable and reasonable for quality control of 147 commercial HLJDT since it could cover the majority of the components. As to the samples HLJDT 01-08, 7 however, the situation is quite different. Only part of the investigated compounds could be determined in these 149 samples with extremely low contents. The total contents of fourteen analytes in these samples existed in a 150 narrow range of about 0.03-1.78%. HLJDT-09 showed a significant improvement with the total content of 151 9.94%, which is still much lower than that of the HLJDT-10.
152
The greatly varied contents of the analytes in the investigated commercial HLJDT samples might be 153 attributed to several reasons. First, confused originals of the compositional herbal materials used in the HLJDT 154 sample preparation with different purposes might make their quality discrepancy. Herbal materials from GAP 155 (Good Agricultural Practices) farms are preferred for quality control purpose. It is also suggested that the 156 quality analysis method itself should not be tested only with self-made sample, validation with representative 157 real sample based on large number of sample batches is more necessary. Second, the inconsistent 158 manufacturing processes followed by different manufacturers, e.g. with/without excipients, could directly 159 affect the contents of individual ingredients. And the existence excipients could also influence the dissolubility 160 and detection of the investigated compounds in the samples. Furthermore, when we check back the instruction 161 of these commercial samples, it is found that all the samples (HLJDT 01-08) collected in China were 162 veterinary medicine while only those from Taiwan and Japan (HLJDT-09 and 10) were human use. The 163 different quality standards of HLJDT samples for veterinary and human use might directly lead to their distinct 164 quality, suggesting that more attention to the quality control of veterinary medicines is also burn-desired.
165
Compared to the reported methods, the current method unprecedentedly reach a high level quantitation of 166 the active ingredients beyond 70% of HLJDT commercial sample, which make it reasonable that Chinese 167 medicine formula, even much more complicated than a single botanical drug, could be brought under desired 168 quantitative control, if the manufacturing process is well designed and the quantitation method is considerate jatrorrihizine; 5, epiberberine; 6, magnoflorine; 7, phellodendrine; 8, baicalein; 9, wogonin; 10, 231 wogonoside; 11, baicalin; 12, geniposide; 13, genipin-1-β-D-gentiobioside; 14, crocin I 232 Tables:   233   Table 1 Contents of fourteen investigated compounds in ten batches of commercial HLJDT samples (mg/g).
234
235 Table 2 Calibration curves, LODs, LOQs, repeatability, accuracy and stability of the HPLC assay of fourteen 236 compounds. Table 1 Contents of fourteen investigated compounds in ten batches of commercial HLJDT samples (mg/g) a The compound numbers are the same as in Fig. 2;  b The data was present as average of triplicate determinations; c The RSD value of triplicate quantitative results (%); d Under the limit of detection (LOD); e LOD value of the corresponding analyte (mg/g); f Under the limit of quantification (LOQ); g LOQ value of the corresponding analyte (mg/g) 
